3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
2
Pancreatic Neoplasms
2
Glioblastoma
2
Breast Neoplasms
2
Pathologic Complete Response
1
Neoplasms
1
Hemangiosarcoma
1
Gliosarcoma
1
Glioma
1
Astrocytoma
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Cyclophosphamide
8
asciminib
7
fludarabine phosphate
6
fludarabine
5
Mycophenolic Acid
5
nilotinib
3
Whole-Body Irradiation
3
Thiotepa
3
Tacrolimus
3
Imatinib Mesylate
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporine
3
venetoclax
2
Sirolimus
2
Melphalan
2
Filgrastim
2
Dasatinib
2
Cyclosporins
2
treosulfan
1
thymoglobulin
1
selinexor
1
ruxolitinib
1
ponatinib
1
plerixafor
1
olverembatinib
1
midostaurin
1
merphos
1
gilteritinib
1
bosutinib
1
blinatumomab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
veliparib
×
30 days
×
Clear all
No trials found.